Astragaloside IV inhibits inflammation caused by influenza virus via reactive oxygen species/NOD‐like receptor thermal protein domain associated protein 3/Caspase‐1 signaling pathway
Immunity, Inflammation and Disease · 2024
DOI: 10.1002/iid3.1309 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, 2024. Verfasst von Xiaoli Huang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, The First College of Clinical Medical Science, China Three Gorges University & Yichang Central People's Hospital, …. Hauptthemen laut MEDLINE: Caspase 1, NLR Family, Pyrin Domain-Containing 3 Protein, Orthomyxoviridae Infections, Reactive Oxygen Species. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Hubei Province, Hubei Provincial Administration of Traditional Chinese Medicine, Hubei Provincial Department of Education.
Abstract (Originalsprache)
Background
Astragaloside IV (AS‐IV) is the most active monomer in the traditional Chinese herbal medicine Radix Astragali , which has a wide range of antiviral, anti‐inflammatory, and antifibrosis pharmacological effects, and shows protective effects in acute lung injury.
Methods
This study utilized the immunofluorescence, flow cytometry, enzyme‐linked immunosorbent assay, quantitative reverse transcription‐polymerase chain reaction, western blot, and hematoxylin and eosin staining methods to investigate the mechanism of AS‐IV in reducing viral pneumonia caused by influenza A virus in A549 cells and BALB/c mice.
Results
The results showed that AS‐IV suppressed reactive oxygen species production in influenza virus‐infected A549 cells in a dose‐dependent manner, and subsequently inhibited the activation of nucleotide‐binding oligomerization domain‐like receptor thermal protein domain associated protein 3 inflammasome and Caspase‐1, decreased interleukin (IL) ‐1β and IL‐18 secretion. In BALB/c mice infected with Poly (I:C), oral administration of AS‐IV can significantly reduce Poly (I:C)‐induced acute pneumonia and lung pathological injury.
Conclusions
AS‐IV alleviates the inflammatory response induced by influenza virus in vitro and lung flammation and structural damage caused by poly (I:C) in vivo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, The First College of Clinical Medical Science, China Three Gorges University & Yichang Central People's Hospital, Yichang, China.
- Central Laboratory, The First College of Clinical Medical Science, China Three Gorges University & Yichang Central People's Hospital, Yichang, China.
- Department of Cardio-Thoracic Surgery, The First College of Clinical Medical Science, China Three Gorges University & Yichang Central People's Hospital, Yichang, China.
ORCID-Profile: Xiaoli Huang, Qiang Liu
Förderung
- Natural Science Foundation of Hubei Province
- Hubei Provincial Administration of Traditional Chinese Medicine
- Hubei Provincial Department of Education
- Yi Chang Scientific and Technological Bureau
Zitieren
APA
Huang, X., Zhou, Y., Li, Y., Wang, T., Chen, Y., Zhou, Y., Zhou, X., & Liu, Q. (2024). Astragaloside IV inhibits inflammation caused by influenza virus via reactive oxygen species/NOD‐like receptor thermal protein domain associated protein 3/Caspase‐1 signaling pathway. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.1309
Vancouver
Huang X, Zhou Y, Li Y, Wang T, Chen Y, Zhou Y, et al. Astragaloside IV inhibits inflammation caused by influenza virus via reactive oxygen species/NOD‐like receptor thermal protein domain associated protein 3/Caspase‐1 signaling pathway. Immunity, Inflammation and Disease. 2024. doi:10.1002/iid3.1309
BibTeX
@article{Huang2024,
author = {Huang, Xiaoli and Zhou, Yifan and Li, Yi and Wang, Ting and Chen, Yandong and Zhou, Yuanhong and Zhou, Xiaolin and Liu, Qiang},
title = {Astragaloside IV inhibits inflammation caused by influenza virus via reactive oxygen species/NOD‐like receptor thermal protein domain associated protein 3/Caspase‐1 signaling pathway},
journal = {Immunity, Inflammation and Disease},
year = {2024},
doi = {10.1002/iid3.1309}
}
EUVIMED